Step-Up Treatment with Premixed Insulin Lispro-50/50 vs. Premixed Human Insulin Aspart-70/30: A Randomized Trial in Type 2 Diabetic Patients

被引：0
|
作者：
Ikeda, Shiori
Monden, Tsuyoshi
Matsumura, Mihoko
Shimizu, Hiroaki
Nakatani, Yuki
Miyashita, Yasushi
Domeki, Nozomi
Yanagi, Kazunori
Kasai, Kikuo
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A142 / A142
页数：1
相关论文
共 50 条
  • [41] Similar glucose control with basal-bolus regimen of insulin detemir plus insulin aspart and thrice-daily biphasic insulin aspart 30 in insulin-naive patients with type-2 diabetes: Results of a 50-week randomized clinical trial of stepwise insulin intensification Experts Commentary
    Wascher, Thomas
    [J]. AUSTRIAN JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 2015, 8 (03): : 88 - 88
  • [42] Efficacy and safety of patient-directed titration of once-daily pre-dinner premixed biphasic insulin aspart 70/30 injection in Japanese type 2 diabetic patients with oral antidiabetic drug failure: STEP-AKITA study
    Narita, Takuma
    Goto, Takashi
    Suganuma, Yumi
    Hosoba, Mihoko
    Morii, Tsukasa
    Sato, Takehiro
    Fujita, Hiroki
    Miura, Takeshi
    Shimotomai, Takashi
    Yamada, Yuichiro
    Kakei, Masafumi
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (01) : 63 - 70
  • [43] Comparison of insulin lispro mix 25 with insulin lispro mix 50 as insulin starter in Chinese patients with type 2 diabetes mellitus (CLASSIFY study): Subgroup analysis of a Phase 4 open-label randomized trial (vol 9, pg 575, 2016)
    Su, Q.
    Liu, C.
    Zheng, H.
    [J]. JOURNAL OF DIABETES, 2018, 10 (05) : 423 - 423
  • [44] Efficacy, Safety, and Quality of Treatment Satisfaction of Premixed Human and Analogue Insulin Regimens in a Large Cohort of Type 2 Diabetic Patients: PROGENS BENEFIT Observational Study
    Nabrdalik, Katarzyna
    Kwiendacz, Hanna
    Sawczyn, Tomasz
    Tomasik, Andrzej
    Kukla, Michal
    Masierek, Malgorzata
    Gumprecht, Janusz
    [J]. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2018, 2018
  • [45] Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trial
    Yang, Wenying
    Zhu, Lvyun
    Meng, Bangzhu
    Liu, Yu
    Wang, Wenhui
    Ye, Shandong
    Sun, Li
    Miao, Heng
    Guo, Lian
    Wang, Zhanjian
    Lv, Xiaofeng
    Li, Quanmin
    Ji, Qiuhe
    Zhao, Weigang
    Yang, Gangyi
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2016, 7 (01) : 85 - 93
  • [46] Comparison of HbA1c in Chinese patients with type 1 or type 2 diabetes randomized to twice daily insulin lispro low mix 25 or twice daily human insulin mix 30/70
    Li Yan
    Li Qiang
    Li Cheng-jiang
    Wang Chang-jiang
    Zheng Yi-man
    Issa, Maher
    Zhang Jia
    [J]. CHINESE MEDICAL JOURNAL, 2009, 122 (21) : 2540 - 2546
  • [47] Six-month multicentric, open-label, randomized trial of twice-daily injections of biphasic insulin aspart 30 versus multiple daily injections of insulin aspart in Japanese type 2 diabetic patients (JDDM 11)
    Hirao, Koichi
    Arai, Keiko
    Yamauchi, Mikio
    Takagi, Hirofumi
    Kobayashi, Masashi
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 (01) : 171 - 176
  • [48] Comparison of the pharmacokinetic and pharmacodynamic profiles of biphasic insulin aspart 50 and 30 in patients with type 2 diabetes mellitus: A single-center, randomized, double-blind, two-period, crossover trial in Japan
    Hirao, Koichi
    Maeda, Hajime
    Urata, Shinichi
    Takisawa, Yukiko
    Hirao, Setsuko
    Sasako, Tatsuya
    Sasaki, Tomio
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (05) : 927 - 934
  • [49] Serum 1,5-anhydroglucitol as a marker of glycemic control in subjects receiving twice-daily biphasic insulin aspart 70/30 (BIAsp 70/30) vs. once-daily insulin glargine in patients with type 2 DM on oral antidiabetic agents
    Moses, A
    Raskin, P
    Hu, P
    Allen, E
    [J]. DIABETES, 2005, 54 : A96 - A96
  • [50] 28-week, randomized, multicenter, open-label, parallel-group phase III trial to investigate the efficacy and safety of biphasic insulin aspart 70 thrice-daily injections vs twice-daily injections of biphasic insulin aspart 30 in patients with type 2 diabetes
    Kadowaki, Takashi
    Nishida, Tomoyuki
    Kaku, Kohei
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2010, 1 (03) : 103 - 110
12345